RPL5 also functions as a tumor suppressor in multiple cancer types, including multiple myeloma, lymphoblastic leukemia, breast cancer, papillary thyroid carcinoma, and rhabdoid tumors38,39. Here, RPL5 is linked to acute lymphoblastic leukemia.